PharmCo III ApS: Financial statements 2022
CVR: 41103647
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
PharmCo III ApS (CVR 41103647) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -27,100 and a net result of DKK 12,142,196 compared with DKK 20,524,284 the year before. Equity in the 2022 report amounted to DKK 50,605,188. The solvency ratio was 55.6%.
- Gross Profit
- DKK -27,100
- Profit/Loss
- DKK 12,142,196
- Equity
- DKK 50,605,188
- Total Assets
- DKK 91,029,513
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -27 t. | 12.1 mio. | 50.6 mio. | - |
| 2021 | 0 | -26 t. | 20.5 mio. | 39 mio. | - |
| 2020 | - | -35 t. | 18.6 mio. | 18.2 mio. | - |
Official annual report
Keep an eye on PharmCo III ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
PharmCo III ApS has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK 20,524,284.
About PharmCo III ApS
PharmCo III ApS is a Danish company of the type Anpartsselskab based in Vojens, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Eli Wallin. The company is owned by Eli Wallin. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -33,000 and a net result of DKK 18,532,000 compared with DKK 13,877,698 the year before. Equity in the 2025 report amounted to DKK 100,696,000.